Blood Products Utilization Status in Off-Pump Cardiac Surgery Patients
Abstract
Background: Transfusion support has an essential role in coronary artery bypass graft (CABG). The time-honored gold standard for CABG is the on-pump procedure (ONCAB); however, off-pump coronary artery bypass (OPCAB) is also a safe, cost-benefit procedure with fewer blood transfusion requirements. This study was performed to evaluate transfusion patterns in OPCAB due to the diversity of transfusion practices.
Materials and Methods: This retrospective study was performed to determine the transfusion rate and triggers in OPCAB patients. Medical files of all patients undergoing OPCAB surgery at Sanandaj Tohid Hospital in 2014 were reviewed. Patients’ demographics data, preoperative laboratory tests (PT, aPTT, Hb, Hct, Platelet count), underlying medical conditions, and their possible relation to further transfusions and the ward department in which the transfusion had taken place were extracted. SPSS 16 Chicago software, T-student Test, One Way Anova, and χ2 exam were applied for data analysis. P values ≤0.05was considered significant.
Results: Among 91 elective OPCAB patients: 28(30.8%) women and 63(69.2%) men with mean age of 64.80±9.02 years, 63(69.23%) received a blood product. Mean utilization of PRBC, FFP, Platelet, and Cryoprecipitate were 2.17±2.044, 2.46±2.86, 2.86±3.80 and 0.40±2.10 units, respectively. ICU revealed the highest consumption rate for all products. Female sex (p<0.001), Hypertension (P=0.002), and low hemoglobin(P=0.004) were noted as predictive factors for transfusion.
Conclusion: This study concluded that the transfusion rate in OPCAB is still very high in Iran (regarding a study in a countryside hospital) and that the highest utilization rate is seen in the ICU.
2. Jenkins I, Doucet JJ, Clay B, et al. Transfusing wisely: clinical decision support improves blood transfusion practices. Jt Comm J Qual Patient Sa. 2017;43(8):389-95.
3. van Hout FM, Hogervorst EK, Rosseel PM, et al. Does a platelet transfusion independently affect bleeding and adverse outcomes in cardiac surgery? Anesthesiology. 2017;126(3):441-9.
4. Lattouf OM, Adams KN, editors. Current readings on off-pump coronary artery bypass. Seminars in thoracic and cardiovascular surgery; 2013: Elsevier.
5. Polomsky M, He X, O’Brien SM, et al. Outcomes of off-pump versus on-pump coronary artery bypass grafting: impact of preoperative risk. J Thorac Cardiovasc Surg. 2013;145(5):1193-8.
6. Lisboa L, Mejía O, Dallan L. Which patients will benefit more from off-pump coronary artery bypass grafting? J Thorac Cardiovasc Surg. 2014;147(1):540-1.
7. McGrath T, Koch CG, Xu M, et al. Platelet transfusion in cardiac surgery does not confer increased risk for adverse morbid outcomes. Ann Thorac Surg. 2008;86(2):543-53.
8. Snyder-Ramos S, Mohnle P, Weng Y, et al. Investigators of the Multicenter Study of Perioperative Ischemia; MCSPI Research Group. The ongoing variability in blood transfusion practices in cardiac surgery. Transfusion 2008;48(7):1284-99.
9. Chen JW, Hsu RB. Impact of surgeon experience on the rate of blood transfusion in off-pump coronary artery bypass. J Formos Med Assoc. 2016;115(3):145-51.
10. Guan Z, Guan X, Gu K, et al. Short-term outcomes of on-vs off-pump coronary artery bypass grafting in patients with left ventricular dysfunction: a systematic review and meta-analysis. J Cardiothorac Surg. 2020;15(1):84.
11. Zubarevich A, Kadyraliev B, Arutyunyan V, et al. On-pump versus off-pump coronary artery bypass surgery for multi-vessel coronary revascularization. J Thorac Dis. 2020;12(10):5639-5646.
12. Kowalewski M, Pawliszak W, Malvindi PG, et al. Off-pump coronary artery bypass grafting improves short-term outcomes in high-risk patients compared with on-pump coronary artery bypass grafting: meta-analysis. J Thorac Cardiovasc Surg. 2016;151(1):60-77.e1-58
13. Kuwahara G, Tashiro T. Current Status of Off-Pump Coronary Artery Bypass. Ann Thorac Cardiovasc Surg. 2020;26(3):125-132
14. Lamy A, Devereaux P, Prabhakaran D, et al. Off-pump or on-pump coronary-artery bypass grafting at 30 days. N Engl J Med . 2012; 366(16):1489-97.
15. Puskas JD, Thourani VH, Kilgo P, et al. Off-pump coronary artery bypass disproportionately benefits high-risk patients. Ann Thorac Surg. 2009;88(4):1142-7.
16. Walczak M, Urbanowicz TK, Tomczyk J, et al. Transfusion of blood products in off-pump coronary artery bypass and conventional coronary artery revascularization. A prospective randomized study. Kardiochir Torakochirurgia Pol . 2014;11(2):136-9.
17. Chung ES, Park KH, Lim C, et al. Risk factors of red blood cell transfusion in isolate off pump coronary artery bypass surgery. Korean J Thorac Cardiovasc Surg . 2012;45(5):301-7.
18. Pagano D, Milojevic M, Meesters MI, et al. 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. J Cardiothorac Vasc Anesth . 2018;32(1):88-120.
19. Puskas JD, Martin J, Cheng DC, et al. ISMICS consensus conference and statements of randomized controlled trials of off-pump versus conventional coronary artery bypass surgery. Innovations (Phila) 2015;10(4):219-29.
20. Casbard A, Williamson L, Murphy M, et al. The role of prophylactic fresh frozen plasma in decreasing blood loss and correcting coagulopathy in cardiac surgery. A systematic review. Anaesthesia. 2004;59(6):550-8.
21. Covin R, O'Brien M, Grunwald G, et al. Factors affecting transfusion of fresh frozen plasma, platelets, and red blood cells during elective coronary artery bypass graft surgery.
Arch Pathol Lab Med. 2003 127(4):415-23.
22. Boldt J, Kling D, von Bormann B, et al. Homologous fresh frozen plasma in heart surgery. Myth or necessity. Anaesthesist. 1989;38(7):353-9.
23. Consten E, Henny CP, Eijsman L, et al. The routine use of fresh frozen plasma in operations with cardiopulmonary bypass is not justified. J Thorac Cardiovasc Surg . 1996;112(1):162-7.
24. Wilhelmi M, Franke U, Cohnert T, et al. Coronary artery bypass grafting surgery without the routine application of blood products: is it feasible? Eur J Cardiothorac Surg. 2001;20(5):1078-9.
25. Contreras M, Ala F, Greaves M, et al. Guidelines for the use of fresh frozen plasma. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force. Transfus Med. 1992;2(1):57-63.
26. Trimble A, Osborn J, Kerth W, et al. The prophylactic use of fresh frozen plasma after extracorporeal circulation. J Thorac Cardiovasc Surg. 1964;48:314-6.
27. Martinowitz U, Goor DA, Ramot B, et al. Is transfusion of fresh plasma after cardiac operations indicated? J Thorac Cardiovasc Surg. 1990;100(1):92-8.
28. Fuller JA, Buxton BF, Picken J, et al. Haematological effects of reinfused mediastinal blood after cardiac surgery. Med J Aust. 1991;154(11):737-40.
29. Momeni M, Carlier C, Baele P, et al. Fibrinogen concentration significantly decreases after on-pump versus off-pump coronary artery bypass surgery: a systematic point-of-care ROTEM analysis. J Cardiothorac Vasc Anesth. 2013;27(1):5-11.
30. Murad MH, Stubbs JR, Gandhi MJ, et al. The effect of plasma transfusion on morbidity and mortality: a systematic review and meta‐analysis. Transfusion. 2010;50(6):1370-83.
31. McQuilten ZK, Andrianopoulos N, Wood EM, et al. Transfusion practice varies widely in cardiac surgery: Results from a national registry. J Thorac Cardiovasc Surg. 2014;147(5):1684-1690.e1.
32. Polomsky M, Puskas JD. Off-pump coronary artery bypass grafting-the current state. Circ J. 2012:76(4): 784-90
33. Alizadeh-Ghavidel A, Totonchi Z, Hoseini A, et al. Blood transfusion practice in a referral cardiovascular center in tehran, iran: a critical point of view. Res Cardiovasc Med. 2014;3(4):e21772
| Files | ||
| Issue | Vol 17, No 3 (2023) | |
| Section | Original Article(s) | |
| DOI | https://doi.org/10.18502/ijhoscr.v17i3.13310 | |
| Keywords | ||
| Cardiac surgical procedure; Blood transfusion; Coronary artery bypass; Off-pump | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
